This CET article will provide a biological understanding of rod-cone dystrophies and why this is important in the context of new treatments and the availability of genetic testing
30 Nov 2019
Jasleen K Jolly MSc, BSc (Hons), MCOptom
To view this content, please log in.
Not a member or subscriber? Join AOP today for access to a whole range of benefits, or subscribe to OT for immediate access to our premium content.